Flex Pharma Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Flex Pharma (FLKS) Tops Q2 EPS by 7c
August 2, 2017 7:38 AM EDTFlex Pharma (NASDAQ: FLKS) reported Q2 EPS of ($0.51), $0.07 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $331 thousand versus the consensus estimate of $520 thousand.
For earnings history and earnings-related data on Flex Pharma (FLKS) click here.
... More